Dr. Roy Chowdhury leads our preclinical and translational research for Qlaris Bio related to our KATP channel modulator platform. Prior to joining Qlaris Bio, he was Assistant Professor of Ophthalmology at Mayo Clinic where he managed and executed pioneering research with Prof. Michael Fautsch in preclinical animal and human models on the effect of KATP […]
Publications & Posters
The below publications outline research from Qlaris Bio's initial formulation, QLS-101. Based on this research, we have now developed a new formulation of our program, called QLS-111.
Ms. Rykard serves as the Executive Assistant to the CEO and CMO, helping to coordinate and orchestrate key office and administrative functions for Qlaris Bio. Prior to joining Qlaris Bio, Ms. Rykard held several administrative roles supporting patient care and office coordination as a Medical Assistant and Administrative Practice Manager at Massachusetts Eye and Ear […]
Mr. DeWalt manages programs across the breadth of the Qlaris Bio portfolio, covering early to clinical stage programs. Prior to joining Qlaris Bio, Mr. DeWalt served as a Project Manager at NXStage Medical, a subsidiary of Fresenius Medical Care focused on the treatment of chronic kidney disease, where he oversaw large cross-functional project teams responsible […]
Mr. Casale manages all activities related to Chemistry, Manufacturing, and Controls at Qlaris Bio for QLS-101 and pipeline programs. Prior to joining Qlaris Bio, Mr. Casale, served as the Technical Project Manager for Bio-Concept Laboratories, Inc. (now Pace), covering project coordination, formulation development, and process development. Before Bio-Concept, he was the Director of Chemistry Operations […]
Ms. Brandano is responsible for managing all aspects of clinical trial operations for Qlaris Bio with a focus on the lead program, QLS-111. Prior to joining Qlaris Bio, Ms. Brandano served as Vice President of Clinical Operations at EyeGate Pharmaceuticals, where she led all clinical operations for their lead and pipeline programs across small molecules […]
Barbara Wirostko, MD, FARVO is Chief Medical Officer and Co-Founder of Qlaris Bio. As a serial entrepreneur and passionate advocate for patients’ needs in ophthalmology, she is responsible for guiding all Qlaris Bio’s medical and clinical development strategy. In addition to her role at Qlaris Bio, she is a practicing glaucoma clinician researcher, holding an […]